Innovating Works

filtrando por convocatoria: HORIZON-HLTH-2023-DISEASE-03-07

Mostrando 1 al 20 de 54 resultados
MARVAX: Development of novel viral vectored vaccines against Marburgviruses inducing robust and cross-reacti... BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 The frequency, magnitude, and geographical range of Marburg virus disease outbreaks are expanding, with recent cases emerging in Equatorial...
2023-11-23 - 2027-11-30 | Financiado
VICI-DISEASE: PROTECTION FROM VIRUSES WITH EPIDEMIC AND PANDEMIC DISEASE OUTBREAK POTENTIAL THROUGH DEVELOPMENT AN... KOBENHAVNS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 The enormous health and economic impacts of epidemics and pandemics has become one of the defining public policy and health issues in Europe...
2023-11-13 - 2027-11-30 | Financiado
NAVIPP: New AntiVirals for Infections with Pandemic Potential EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 For infectious disease management and control, vaccines are considered golden countermeasures. but are not the most adequate tool for mitiga...
2023-11-22 - 2028-12-31 | Financiado
SOLVE: Sustainable COVID-19 Vaccination for Long-term Vaccine Immunity and Effectiveness INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Despite the rapid development of various SARS-CoV-2 vaccines, the control of the pandemic is hampered by the constant emergence of SARS-CoV-...
2023-12-08 - 2028-12-31 | Financiado
Yellow4FLAVI: Deconstructing the protective immunity of yellow fever virus 17D to inform flavivirus vaccine design INSTITUT PASTEUR tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 While endemic to the tropics, flaviviruses like Zika, dengue, West Nile or yellow fever virus are re-emerging pathogens of global health con...
2023-11-14 - 2028-12-31 | Financiado
EU PAL-COPD: Evaluation of the ICLEAR-EU intervention to integrate palliative care in the treatment of people wit... VRIJE UNIVERSITEIT BRUSSEL tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Chronic Obstructive Pulmonary Disease (COPD) is a devastating life-limiting lung disease with a high personal and societal burden. Worldwide...
2023-12-08 - 2028-12-31 | Financiado
EvaMobs: Evolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform UNIVERSIDADE NOVA DE LISBOA tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 With progress in globalization, expansion of human populations into natural habitats, and aggravation of climate change comes an increased r...
2023-11-23 - 2028-12-31 | Financiado
FLAVIVACCINE: Development and characterization of a pan-flavivirus vaccine candidate INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Dengue, yellow fever, Zika, and West Nile viruses are mosquito-borne flaviviruses and global public health burdens that infect half a billio...
2023-12-13 - 2027-12-31 | Financiado
e-FabRIC: enhanced manufacturing of broadly potent equine polyclonal Fab with a Rational Immunization strategy... FABENTECH tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 E-FabRIC will develop a new hyperimmunization strategy for generating high titers equine immunoglobulins having a broad neutralizing specifi...
2023-12-07 - 2027-11-30 | Financiado
PANVIPREP: Developing broad-spectrum antiviral drugs for pandemic preparedness ACADEMISCH ZIEKENHUIS LEIDEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Antiviral drugs will be key in the management of future virus outbreaks. For each virus family with epidemic/pandemic potential, stockpiles...
2024-01-01 - 2027-12-31 | Financiado
ID-DarkMatter-NCD: Unraveling the dark matter of infectious diseases, environmental and genetic factors tipping the bal... MEDIZINISCHE UNIVERSITAET WIEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 While it is known that post-COVID-19-condition (PCC) is caused by SARS-CoV-2 infection, for most other immune-related noncommunicable diseas...
2024-01-01 - 2028-12-31 | Financiado
Changemaker: Promoting co-designed sustainable health interventions with young changemakers for reduced risk of n... KAROLINSKA INSTITUTET tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Changemaker objective: To implement & evaluate a sustainable health intervention program on health, nutrition, & environmental outcomes for...
2024-01-01 - 2027-12-31 | Financiado
CCHFVACIM: Crimean-Congo Haemorrhagic Fever Vaccine and Immunotherapy FOLKHALSOMYNDIGHETEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 The CCHFVACIM project is an ambitious collaborative effort aimed at developing both prophylactic and therapeutic effective countermeasures a...
2024-01-01 - 2027-12-31 | Financiado
CLARITY: Causative Link between respirAtory syncytial viRus and chronic lung diseases: Identifying Targets fo... UNIVERSITAIR MEDISCH CENTRUM UTRECHT tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Chronic respiratory diseases are non-communicable diseases for which infections by several respiratory viruses and human genetics constitute...
2024-01-01 - 2028-12-31 | Financiado
POINT: Preventing non-communicable diseases caused by the post-acute phase of cOvid-19 INfecTion KOBENHAVNS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 The post-acute phase (PAP) of COVID-19, occurring ≥4 months after the acute phase, is associated with an increased risk for the development...
2024-01-01 - 2027-12-31 | Financiado
RAPHAEL: INTEGRATING A PALLIATIVE CARE APPROACH FOR PATIENTS WITH HEART FAILURE UNIVERSITAIR MEDISCH CENTRUM UTRECHT tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 While the need for integrating palliative care (PC) services into heart failure (HF) care has been well recognised, as of yet this integrati...
2024-01-01 - 2028-12-31 | Financiado
BEHIND-MS: The role of an Epstein-Barr virus infection in the pathogenesis of multiple sclerosis DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Multiple Sclerosis (MS) is the most frequent neuroinflammatory disease. Despite new treatments that slow the progression of the disease, pat...
2023-12-01 - 2028-11-30 | Financiado
Homi-lung: Long-term alterations of host-microbiome interactions and cardiovascular and respiratory diseases pr... NANTES UNIVERSITE tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Challenges. The incidence of cardiovascular diseases (CVD) increases after infections, but causal mechanisms are not understood yet. Pneumon...
2024-01-01 - 2028-12-31 | Financiado
BEATsep: Biomarkers established to stratify sepsis long-term adverse effects to improve patients’ health and... FAKULTNI NEMOCNICE U SV ANNY V BRNE tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Sepsis is a life-threatening organ dysfunction resulting from dysregulated immune responses to infection, affecting almost 50 million people...
2024-01-01 - 2028-12-31 | Financiado
CSA BrainHealth: Designing a European Brain Health Landscape DEUTSCHES ZENTRUM FUR LUFT UND RAUMFAHRT EV tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 The Coordination and Support Action (CSA) BrainHealth will lay the ground for an envisaged ‘European Partnership (EP) on Brain Health’. Twen...
2023-11-01 - 2025-10-31 | Financiado